Skip to Main Content

Author Details

Maura Gasparetto
University of Colorado School of Medicine
1998
30
18
PMIDPaper TitleJournal TitlePublished Year
37358260A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.Cancer Discov2023
36194842Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.JCO Clin Cancer Inform2022
30852438Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy.Leuk Res2019
30943405The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells.Cell Rep2019
28645468ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers.Chem Biol Interact2017
28280079Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.Haematologica2017
28881356Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.Br J Cancer2017
27374788Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.Cell Stem Cell2016
25427917The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis.Adv Exp Med Biol2015
24641679Aldehyde dehydrogenases in acute myeloid leukemia.Ann N Y Acad Sci2014
25339361Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13.Blood2014
22987615Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice.Int J Cancer2013
24061865Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice.Cancer Chemother Pharmacol2013
22198153Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development.Exp Hematol2012
22683567Varying levels of aldehyde dehydrogenase activity in adult murine marrow hematopoietic stem cells are associated with engraftment and cell cycle status.Exp Hematol2012
21730353Prolonged self-renewal activity unmasks telomerase control of telomere homeostasis and function of mouse hematopoietic stem cells.Blood2011
21865344Ontogeny stage-independent and high-level clonal expansion in vitro of mouse hematopoietic stem cells stimulated by an engineered NUP98-HOX fusion transcription factor.Blood2011
19531228FuGEFlow: data model and markup language for flow cytometry.BMC Bioinformatics2009
19749980A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.PLoS Genet2009
19377048Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential.Blood2009
18752282MIFlowCyt: the minimum information about a Flow Cytometry Experiment.Cytometry A2008
17330101Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.Leukemia2007
17531779High-content flow cytometry and temporal data analysis for defining a cellular signature of graft-versus-host disease.Biol Blood Marrow Transplant2007
17577930Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusions.Exp Hematol2007
17366638Data quality assessment of ungated flow cytometry data in high throughput experiments.Cytometry A2007
19343108Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public health.Integr Comp Biol2006
15350512Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening.J Immunol Methods2004
12941844Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.Cancer Res2003
12090755Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF.Cytokine2002
9765686Induction chemotherapy followed by simultaneous hyperfractionated radiochemotherapy in advanced head and neck cancer. A pilot study.Strahlenther Onkol1998
  • 1 - 30 of 30

Recommended Authors

Pavana Anur
Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 4
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 3
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 1
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 1
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 6
Sergei Doulatov
University of Washington
Career Start Year 2002
Number of shared co-authors 0
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 3
Jalila Chagraoui
Institute for Research in Immunology and Cancer, University of Montreal
Career Start Year 2000
Number of shared co-authors 1
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 1
Peter Kurre
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 2
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 5
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Kolja Eppert
McGill University
Career Start Year 1996
Number of shared co-authors 1
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 1
Wendy Hu
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 1
Ravi Bhatia
University of Alabama at Birmingham
Career Start Year 1992
Number of shared co-authors 4
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 2
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 2
Scott A Armstrong
Boston Children's Hospital
Career Start Year 1990
Number of shared co-authors 7
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 2
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year 1989
Number of shared co-authors 0
Jana Krosl
The Leucegene Project at Institute for Research in Immunology and Cancer.
Career Start Year 1989
Number of shared co-authors 2
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 0
Marcela Gronda
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 1
John E Dick
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 3
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 4
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 0
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 2

Collaborators

Clayton A Smith
University of Colorado, Aurora CO.
Co-authored papers 14
Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 7
Shanshan Pei
Zhejiang University Medical Center
Co-authored papers 6
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 5
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 5
Mohammad Minhajuddin
University of Colorado School of Medicine
Co-authored papers 5
Ryan R Brinkman
University of British Columbia
Co-authored papers 4
Maria Amaya
University of Colorado School of Medicine
Co-authored papers 2
Olga Tchuvatkina
Fox Chase Cancer Center, Temple University Health
Co-authored papers 2
Haobin Ye
Institute of Metabolism & Integrative Biology, Fudan University
Co-authored papers 2
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Co-authored papers 2
Peter Wilkinson
Case Western Reserve University
Co-authored papers 2
David A Rizzieri
Duke University Medical Center
Co-authored papers 2
Biniam Adane
The Broad Institute of MIT and Harvard
Co-authored papers 2
Richard H Scheuermann
J. Craig Venter Institute
Co-authored papers 2
Josef Spidlen
British Columbia Cancer Research Center
Co-authored papers 2
Yu Qian
J. Craig Venter Institute
Co-authored papers 2
James C S Wood
Comprehensive Cancer Center
Co-authored papers 1
Christopher B Wilson
Drukier Institute for Children's Health
Co-authored papers 1
Guy Sauvageau
Universite de Montreal
Co-authored papers 1
Y Megan Kong
Centro Hospitalar Conde de Sao Januario
Co-authored papers 1
Vadym Zaberezhnyy
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Elizabeth Goralczyk
Co-authored papers 1
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Co-authored papers 1
Gregg Duester
Co-authored papers 1
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 1
Biruntha Selvaraj
Co-authored papers 1
Peter Atadja
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Mark Dalphin
Co-authored papers 1
Release 1.2